Memphasys Completes maiden sale of Felix
- Reproduction biotechnology and bio-separations company Memphasys (MEM) completes the maiden sale of Felix
- The sale was made to Diagens Biotechnology, which is a Chinese company that manufacturers and distributes human reproduction products across China
- This represents a major milestone for Memphasy as it increases its exposure to the Chinese market, which is the largest IVF market in the world
- Felix is Memphasy novel device that quickly and gently separates high-quality sperm from a sample for use in IVF procedures
- The company was up 14.3 per cent on the market with shares trading at 12 cents
